Co-Injection of patient-derived fibroblasts enhances tumor growth, stromal invasion, and epithelial-to-mesenchymal transition
Ines Lohse(University Hospital of Zurich), David W. Hedley(Ontario Institute for Cancer Research)
Cited by 3
Related Papers
Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer
|British Journal of Cancer|2008|155
Activity of a novel, dual PI3-kinase/mTor inhibitor NVP-BEZ235 against primary human pancreatic cancers grown as orthotopic xenografts
|British Journal of Cancer|2009|124
Suppression of the Hypoxia-Inducible Factor-1 Response in Cervical Carcinoma Xenografts by Proteasome Inhibitors
|Cancer Research|2007|58
Pharmacodynamic monitoring of BAY 43‐9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cells
|Cytometry Part B Clinical Cytometry|2006|52
Single‐cell measurement of the uptake, intratumoral distribution and cell cycle effects of cisplatin using mass cytometry
|International Journal of Cancer|2014|42